Electrolyte disturbances cardiovascular tests
1 / 45

Electrolyte disturbances Cardiovascular Tests - PowerPoint PPT Presentation

  • Uploaded on

Electrolyte disturbances Cardiovascular Tests. Definitions!. Protons + are positively charged particles ( atomic number is the number of protons) example H+ Electrons - are the negatively charged particles that spin Neutrons uncharged particles that spin and are made up of quarks

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about ' Electrolyte disturbances Cardiovascular Tests' - gage-pierce

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Electrolyte disturbances cardiovascular tests

Electrolyte disturbancesCardiovascular Tests


  • Protons + are positively charged particles (atomic number is the number of protons) example H+

  • Electrons - are the negatively charged particles that spin

  • Neutronsuncharged particles that spin and are made up of quarks

  • “A neutron walked into a bar and asked how much for a drink. 

  • The bartender replied,  "for you, no charge." 

    -Jaime - Internet Chemistry Jokes

Acid base balance and the blood


[OH -]


Alkaline (Basic)




Venous Blood

Arterial Blood











Small changes in ph can produce major disturbances
Small changes in pH can produce major disturbances

  • Most enzymes function only with narrow pH ranges

  • Acid-base balance can also affect electrolytes (Na+, K+, Cl-)

  • Can also affect hormones

The body produces more acids than bases
The body produces more acids than bases

  • Acids take in with foods

  • Acids produced by metabolism of lipids and proteins

  • Cellular metabolism produces CO2.

  • CO2 + H20 ↔ H2CO3 ↔ H+ + HCO3-

Control of acids
Control of Acids

  • Buffer systems

    Take up H+ or release H+ as conditions change

    Buffer pairs – weak acid and a base

    Exchange a strong acid or base for a weak one

    Results in a much smaller pH change

Acidosis 392
Acidosis (392)

  • Principal effect of acidosis is

    depression of the CNS through ↓ in synaptic transmission.

  • Generalized weakness

  • Deranged CNS function is

    the greatest threat

  • Severe acidosis causes

    • Disorientation

    • coma

    • death


  • Alkalosis causes over excitability of the central and peripheral nervous systems.

  • Numbness

  • Lightheadedness

  • It can cause :

    • Nervousness

    • muscle spasms or tetany

    • Convulsions

    • Loss of consciousness

    • Death

Anion gap
Anion Gap

  • The difference between [Na+] and the sum of [HC03-] and [Cl-].

    • [Na+] – ([HC03-] + [Cl-]) =

      • 140 - (24 + 105) = 11

        • Normal = 12 + 2

  • Clinicians use the anion gap to identify the cause of metabolic acidosis.

  • Electrolytes

    • Calcium (428-429)

    • Sodium(430)

    • Potassium(175)

    • Magnesium(148)

    • Phosphorus(170)

    CALCIUM life-threatening consequences. 

    • Hypocalcemia

    • Symptoms

      • Tetany, seizures

      • Circumoral numbness

      • Paresthesias

      • Carpopedal spasm

      • Latent tetany may result in Trousseau and Chvostek signs

      • Electrocardiogram (EKG) – prolonged QT, Torsades de Pointes

    Hypercalcemia life-threatening consequences. 

    • Causes

    • Hyperparathyroidism

    • Cancer with bone metastasis (in particular prostate and breast)

    Potassium k
    Potassium (K) life-threatening consequences. 

    • Cellular distribution affected by insulin and beta-adrenergic receptors, renal excretion

    • 3 mechanisms control potassium

    • Intake

    • Distribution between intracellular and extracellular fluid

    • Renal excretion

    • Rapid changes have life-threatening consequences

    • May affect serum pH (inverse relationship)

    Hypokalemia life-threatening consequences. 


    Drugs (diuretics, beta agonists)

    Diarrhea (laxative abuse)

    Diabetes (uncontrolled)

    Inadequate intake

    • Defined as:

      • Mild: 3-3.2 mmol/L

      • Moderate: 2.5-2.9 mmol/L

      • Severe: <2.5 mmol/L

    • Symptoms

    • May vary from asymptomatic to fulminant respiratory failure

    • Most commonly manifests as weakness, fatigue

    • EKG – prolonged QT, Torsade de Pointes

    HYPERKALEMIA life-threatening consequences. 


    Metabolic acidosis



    Tumor lysis syndrome


    Renal failure

    • Defined as:

    • Mild: >5.1-6.0 mmol/L

    • Moderate: 6.1-7 mmol/L

    • Severe: >7 mmol/L

    • Symptoms

    • Usually only occur above 7 mmol/L

    • Muscle weakness, cardiac arrhythmias

    • EKG – peaked waves, widening of QRS

    Sodium na
    Sodium (Na) life-threatening consequences. 


    thiazide diuretics, osmotic diuresis, adrenal insufficiency, ketonuria

    syndrome of inappropriate antidiuretic hormone (SIADH), hypothyroidism, HIV, certain forms of cancer

    psychogenic polydipsia, multiple tap water enemas, congestive heart failure

    • Normal range: 136-144 mmol/L

    • Sodium-related disorders

    • Hyponatremia

      • Defined as <136 mmol/L

      • Symptoms

      • Headache, nausea, emesis, lethargy

      • Severe hyponatremia can cause seizures, coma, death

    Hypernatremia life-threatening consequences. 

    • Defined as serum sodium >144 mmol/L

    • Symptoms:

    • Mimics symptoms of hyponatremia

    • Causes

    • Insensible losses (e.g., fever)

    • Diabetes insipidus (central, nephrogenic)

    • Cushing disease

    • Hyperaldosteronism

    Magnesium mg
    Magnesium (Mg) life-threatening consequences. 

    • Physiologically – magnesium aids in cellular transport of Ca, Na, K

    • Balance maintained by kidneys

    • Normal range in serum: 1.6-2.6 mg/dL

    Hypomagnesemia life-threatening consequences. 


    Gastrointestinal losses – diarrhea, small bowel surgery, malabsorption, pancreatitis

    Renal losses – diuretics, nephrotoxic drugs, tubular necrosis

    Uncontrolled diabetes mellitus

    • Is a common disorder

    • Symptoms

    • Neurologic manifestations similar to hypocalcemia

    • Tetany, muscle weakness, Chvostek and Trousseau signs

    • EKG – widening QRS or QT and peaked T waves, premature ventricular contractions (PVCs)

    Hypermagnesemia life-threatening consequences. 


    Impaired renal function

    Patient receiving large load of magnesium or magnesium-containing drugs

    Parenteral magnesium therapy for preeclampsia

    Elderly patients with gastrointestinal disease on cathartics

    • Defined as serum Mg >2.6 mg/dL

    • Symptoms

    • Usually mild elevation and therefore no symptoms

    • Symptoms when Mg ≥4 mg/dL

      • 4-6 mg/dL: nausea, lethargy, flushing

      • 6-10 mg/dL: somnolence, hypocalcemia, hypotension, bradycardia

      • >10 mg/dL: respiratory paralysis, complete heart block, cardiac arrest

    Phosphorus life-threatening consequences. 

    • Phosphates are vital for energy production, muscle and nerve function, and bone growth

    • An important role as a buffer, helping to maintain the body’s acid-base balance

    • 70% to 80% as calcium phosphate – bones/teeth

    • 10% in muscle

    • 1% in nerve

    • Beans, peas and nuts, cereals, dairy products, eggs, beef, chicken, and fish contain significant amounts of phosphorus

    • Intestinal absorption and renal excretion maintains blood levels

    Phosphorus life-threatening consequences. 

    • Phosphorus testing often is performed as a follow-up to an abnormal calcium level and/or related symptoms, such as fatigue, muscle weakness, cramping, or bone problems

    • To ensure patient is not excreting or retaining excessive amounts in the presence of kidney disorder, kidney stones, or uncontrolled diabetes

    Phosphorus life-threatening consequences. 

    • Also known as P, PO4, Phosphate

    • When to get tested?

    • As a follow-up to:

    • an abnormal calcium level

    • kidney disorder

    • uncontrolled diabetes, and

    • On calcium or phosphate supplements

    Hypophosphatemia life-threatening consequences. 

    • Dietary deficiencies in phosphorus are rare but may be seen with alcoholism and malnutrition

    • May be associated with:

    • Hypercalcemia, especially due to hyperparathyroidism

    • Overuse of diuretics

    • Severe burns

    • Diabetic ketoacidosis (after treatment)

    • Hypothyroidism

    • Hypokalemia

    • Chronic antacid use

    • Rickets and osteomalacia (due to Vitamin D deficiencies)

    Hyperphosphatemia life-threatening consequences. 

    • May be due to or associated with:

    • Kidney failure

    • Hypoparathyroidism (underactive parathyroid gland)

    • Diabetic ketoacidosis (when first seen)

    • Phosphate supplementation

    Cardiovascular tests

    Cardiovascular Tests life-threatening consequences. 

    Step 1 determine lipoprotein levels obtain complete lipoprotein profile after 9 to 12 hour fast 78
    STEP 1: Determine lipoprotein levels - obtain complete lipoprotein profile after 9- to 12-hour fast (78)

    • ATP III Classification of LDL, Total, and HDL Cholesterol (mg/dL)

    • LDL Cholesterol - Primary Target of Therapy

    Total cholesterol
    Total Cholesterol lipoprotein profile after 9- to 12-hour fast

    Determine presence of major risk factors
    Determine presence of major risk factors lipoprotein profile after 9- to 12-hour fast

    • Major Risk Factors (Exclusive of LDL Cholesterol)

      That Modify LDL Goals

    • Cigarette smoking

    • Hypertension (BP 140/90 mmHg or on antihypertensive medication)

    • Low HDL cholesterol (<40 mg/dl)*

    • Family history of premature CHD (CHD in male first degree relative <55 years; CHD in female first degree relative <65 years)

    • Age (men 45 years; women 55 years)

    • * HDL cholesterol 60 mg/dL counts as a "negative" risk factor; its presence removes one risk factor from the total count.

    • Note: in ATP III, diabetes is regarded as a CHD risk equivalent.

    Identify metabolic syndrome and treat if present after 3 months of tlc
    Identify metabolic syndrome and treat, if present, after 3 months of TLC.

    Clinical Identification of the Metabolic Syndrome - Any 3 of the Following:

    Treat elevated triglycerides 207
    Treat elevated triglycerides. (207) months of TLC

    ATP III Classification of Serum Triglycerides (mg/dL)

    Coronary risk screen
    Coronary Risk Screen months of TLC

    • CHOLESTEROL: is normally synthesized by the liver and is important as a constituent of cell membranes and a precursor to steroid hormones. Its level in the bloodstream can influence the pathogenesis of certain conditions, such as the development of atherosclerotic plaque and coronary artery disease

    • TRIGLYCERIDES: Triglycerides are esters of glycerol and fatty acids. Since they and cholesterol travel in the blood stream together, they should be assessed together.

    • HDL: A complex of lipids and proteins in approximately equal amounts that functions as a transporter of cholesterol in the blood. High levels are associated with a decreased risk of atherosclerosis and coronary heart disease.

    • LDL: A complex of lipids and proteins, with greater amounts of lipid than protein, which transports cholesterol in the blood.

    • CHOL/HDL RATIO: A ratio of lipids for determining possible cardiac risk factors.

    High risk group
    High Risk months of TLCGroup

    • Have either CAD or any one of five CAD "risk equivalents":

    • Diabetes mellitus

    • Peripheral vascular disease

    • Carotid artery disease

    • Abdominal aortic aneurysm

    • A calculated 10-year risk for a coronary event that exceeds 20%

    Characterized by five major abnormalities
    Characterized by five major abnormalities months of TLC

    1.   Obesity (central body and visceral)

    2.   Hypertension

    3.   Insulin resistance (hyperinsulinemia)

    4.   Glucose intolerance

    5. Dyslipidaemia

    Emerging risk factors
    Emerging Risk Factors months of TLC

    • Lipoprotein (a)

    • C-reactive protein (66)

    • Homocysteine (133)

    • Prothrombotic factors

    • Proinflammatory factors

    • Impaired fasting glucose

    • Subclinical atherosclerosis

    Other predictors


    CHD risk factors

    Tests for acute heart attacks myocardial infarction


    • TROPONINS(209)

    • Creatine Kinase (CK)(87)

    • CK is an enzyme found in the heart and muscles. Increased CK-MB is seen with heart muscle damage.

    • Increased CK-MM is noted with skeletal muscle injury. Strenuous exercise, weight lifting, surgical procedures, high doses of aspirin and other medications can elevate CK.

    Troponin t ctnt
    Troponin T (cTNT) months of TLC

    • Troponin T is a protein found in the blood and is related to contraction of the heart muscle.

    • Troponin T is valuable for detecting heart muscle damage and risk.

    Ultra sensitive c reactive protein us crp 66
    Ultra Sensitive C-reactive Protein (US-CRP)(66) months of TLC

    • Goal values:

    • Less than 1.0 mg/L = Low Risk for CVD

    • 1.0-2.9 mg/L = Average Risk for CVD

    • Greater than 3.0 mg/L High Risk for CVD

    • (levels above these ranges indicate increased risk for heart and blood vessel disease)

    B type natriuretic peptide bnp blood test
    B-Type Natriuretic Peptide (BNP) blood test months of TLC

    • BNP is a substance secreted from the ventricles or lower chambers of the heart in response to changes in pressure that occur when heart failure develops and worsens.

    • Increases when heart failure symptoms worsen, and decreases when the heart failure condition is stable.

    B type natriuretic peptide bnp blood test1
    B-Type Natriuretic Peptide (BNP) blood test months of TLC

    • BNP levels below 100 pg/mL indicate no heart failure

    • BNP levels of 100-300 suggest heart failure is present

    • BNP levels above 300 pg/mL indicate mild heart failure

    • BNP levels above 600 pg/mL indicate moderate heart failure.

    • BNP levels above 900 pg/mL indicate severe heart failure.

    • BNP accurately detected heart failure 83% of the time and reduced clinical indecision from 43% to 11%.

      -January 2008 issue of the Journal of the American College of Cardiology

    Homocysteine hcy 133
    Homocysteine (Hcy) months of TLC (133)

    • An amino acid. High levels are related to early development of heart and blood vessel disease

    • Goal value: less than 10 umol/L

    • High levels of homocysteine are related to the early development of heart and blood vessel disease. In fact, it is considered an independent risk factor for heart disease.

    • High homocysteine is associated with low levels of vitamin B6, B12 and folate and renal disease.

    • For the most accurate results, wait at least two months after a heart attack, surgery, infection, injury or pregnancy to check this blood level.

    • Evaluation of hyperlipidemia (431)